Bacopa monnieri/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases adverse event occurrence (oral or enteral supplement)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Bacopa monnieri supplementation was generally well-tolerated, with no serious adverse reactions, although there was a greater frequency of self-reported adverse reactions in the Bacopa monnieri group (p = 0.024), primarily comprising digestive complaints and headaches.”
Quoted verbatim from The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 300 mg daily
- Population
- Adults aged 40-70 years with self-reported memory and attention problems
The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.2025PMID:41091332Permalink
Keep reading
- Everything the graph holds on Bacopa monnieri
- Every compound studied against Adverse event occurrence (oral or enteral supplement)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1JGKSCJ0VXX6H4Q32HCHDPF